Evidence map›Paper›PMID 25589442›Full record

ArticleArchives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists2015

Interactive effects of neurocognitive impairment and substance use on antiretroviral non-adherence in HIV disease.

Nicholas S Thaler, Philip Sayegh, Michelle S Kim, Steven A Castellon, Charles H Hinkin

Open access · bronzeAbstract read
In one paragraph

Article in Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 31 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Psychometrics and Validity of the Survey of Memory-Related Quality of Life in HIV Disease.Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists · 2021
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Nicholas S ThalerDepartment of Psychiatry and Biobehavioral Sciences, UCLA Geffen School of Medicine, Los Angeles, CA, USA Nthaler@mednet.ucla.edu.
Philip SayeghDepartment of Psychiatry and Biobehavioral Sciences, UCLA Geffen School of Medicine, Los Angeles, CA, USA.
Michelle S KimDepartment of Neurology, University of Washington, Seattle, WA, USA.
Steven A CastellonDepartment of Psychiatry and Biobehavioral Sciences, UCLA Geffen School of Medicine, Los Angeles, CA, USA Department of Psychology, VA Greater Los Angeles Healthcare System, Los Angeles, CA, USA.
Charles H HinkinDepartment of Psychiatry and Biobehavioral Sciences, UCLA Geffen School of Medicine, Los Angeles, CA, USA Department of Psychology, VA Greater Los Angeles Healthcare System, Los Angeles, CA, USA.
Neurobehavioral Systems · USUniversity of Washington · US

Funding

NEUROSPYCHOLOGY AIDS FELLOWSHIPT32MH019535 · NIMH · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI HINKIN, CHARLES H · 1991 to 2017
$2.3M
Predictors: Medication Adherence in HIV+ Cocaine AbusersR01DA013799 · NIDA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI HINKIN, CHARLES H · 2001 to 2004
$2.3M
NIDA NIH HHS R01 DA013799NIDA NIH HHS R01 DA13799NIMH NIH HHS T32 MH019535NIMH NIH HHS T32 MH19535
6 · The paper itself

Abstract

While numerous studies have established the adverse independent effects of clinical conditions including neurocognitive dysfunction, psychiatric illness, and substance abuse/dependence on medication adherence among HIV-infected adults, fewer have studied their interactive effects. The current study examined this issue among 204 HIV-infected participants based upon current neurocognitive functioning and DSM-IV-diagnosed psychiatric illness and current substance abuse or dependence. Results confirmed that participants with any of these risk factors demonstrated poorer adherence than individuals with no risk factors. A neurocognitive status × substance abuse/dependence interaction was also identified such that participants with impaired neurocognition and a co-occurring substance abuse/dependence diagnosis demonstrated the poorest adherence. Results confirm the deleterious impact of these risk factors in isolation and also identify a specific interactive effect for individuals with comorbid neurocognitive impairment and a substance abuse/dependence disorder. Findings highlight the need for interventions that simultaneously address these problems.

Indexed as

AdultAntiretroviral Therapy, Highly ActiveCognition DisordersDrug MonitoringFemaleHIV InfectionsHumansMaleMedication AdherenceMiddle AgedNeuropsychological TestsPsychiatric Status Rating ScalesSubstance-Related DisordersDrug and alcohol abuseHIV/AIDS

Identifiers

PMID25589442
PMCPMC4402335
OpenAlexW2057939743

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.